HCPCS Code for Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Q2053
HCPCS code Q2053 for Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose as maintained by CMS falls under Other Drugs and Service Fees .
Subscribe to Codify by AAPC and get the code details in a flash.
Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Tabs
Match supply and drug codes in a snap. View corresponding CPT® codes and their definitions.
Tabs
Subscribers see the ICD-10-CM codes a contractor allows and full LCD policy text on the same website.
Protect Part B Payments by complying with Correct Coding Initiative (CCI) edits. Subscribers see the full list of column 2 codes for the searched HCPCS code.
Read a HCPCS Coding Clinic® article by subscribing today.